Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Oct;43(5):1154-1158.
doi: 10.1111/ijlh.13469. Epub 2021 Jan 18.

Features of serum complement C3 and C4 levels in autoimmune hemolytic anemia patients

Zhao Wang  1 , Lijin Bo  1 , Yan Xu  1 , Huijuan Liu  1 , Yuping Zhao  1
Affiliations

Features of serum complement C3 and C4 levels in autoimmune hemolytic anemia patients

Zhao Wang et al. Int J Lab Hematol. 2021 Oct.

Abstract

Introduction: Abnormally activated complement system induces erythrolysis in a part of autoimmune hemolytic anemia (AIHA) patients. However, the alterations in serum complement levels in these patients are seldom reported. In this study, we aimed to evaluate the serum complement features of AIHA patients according to different clinical and laboratory characteristics and to find relationships between complement levels and hemolysis-associated laboratory indexes.

Methods: A retrospective analysis of 146 AIHA patients was performed, and serum complement C3 and C4 levels were compared between control subjects and AIHA patients with different subtypes. Correlations of serum C3/C4 levels with titers of cold agglutinin test (CAT), direct antiglobulin test (DAT), and serological indexes were assessed. Spearman correlation analysis was performed to analyze the relationship between serum complement levels and other laboratory indexes.

Results: Autoimmune hemolytic anemia patients showed reduced serum C3 levels, while serum C4 levels tended to be lower in DAT-positive AIHA patients but not in DAT-negative AIHA patients. Patients with warm AIHA secondary to connective tissue diseases and cold agglutinin disease/cold agglutinin syndrome had the lowest serum C3/C4 levels. Serum C4 levels were negatively correlated with CAT (P = .004) and DAT (anti-C3d) (P = .007) titers. In patients with positive CAT and/or DAT (anti-C3d) but negative DAT (anti-IgG), serum C3/C4 levels were negatively correlated with indirect bilirubin (P = .017 and =.026, respectively).

Conclusion: The study findings may be helpful in not only unraveling the mechanism underlying hemolysis in AIHA but also diagnosing AIHA and selecting targeted treatment strategies.

Keywords: autoimmune hemolytic anemia; complement; direct antiglobulin test; laboratory features.

PubMed Disclaimer

References

REFERENCES

    1. Yilmaz F, Vural F. Autoimmune hemolytic anemia: focusing on therapy according to classification. SOJ Immunol. 2017;5(1):1-6. https://doi.org/10.15226/2372
    1. Hauswirth AW, Skrabs C, Schützinger C, Gaiger A, Lechner K, Jäger U. Autoimmune hemolytic anemias, Evans' syndromes, and pure red cell aplasia in non-Hodgkin lymphomas. Leuk Lymphoma. 2007;48(6):1139-1149. https://doi.org/10.1080/10428190701385173
    1. Gomard-Mennesson E, Ruivard M, Koenig M, et al. Treatment of isolated severe immune hemolytic anaemia associated with systemic lupus erythematosus: 26 cases. Lupus. 2006;15(4):223-231.
    1. Berentsen S, Sundic T. Red blood cell destruction in autoimmune hemolytic anemia: role of complement and potential new targets for therapy. BioMed Res Int. 2015;2015:e363278. https://doi.org/10.1155/2015/363278
    1. Jäger U, Barcellini W, Broome CM, et al. Diagnosis and treatment of autoimmune hemolytic anemia in adults: recommendations from the first International Consensus Meeting. Blood Rev. 2020;41:e100648. https://doi.org/10.1016/j.blre.2019.100648

LinkOut - more resources